Detalhe da pesquisa
1.
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial.
Ann Oncol
; 34(5): 468-476, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36863484
2.
Cell-free DNA concentration and fragment size fraction correlate with FDG PET/CT-derived parameters in NSCLC patients.
Eur J Nucl Med Mol Imaging
; 48(11): 3631-3642, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33797597
3.
Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors.
Ann Oncol
; 31(2): 274-282, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31959344
4.
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types.
Ann Oncol
; 29(10): 2121-2128, 2018 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30165419
5.
Nintedanib selectively inhibits the activation and tumour-promoting effects of fibroblasts from lung adenocarcinoma patients.
Br J Cancer
; 117(8): 1128-1138, 2017 Oct 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28898237
6.
Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions.
Ann Oncol
; 28(9): 2248-2255, 2017 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28911086
7.
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upâ.
Ann Oncol
; 32(7): 839-853, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33864941
8.
[Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology]. / Recomendaciones para el diagnóstico radiológico y la valoración de la respuesta terapéutica en el cáncer de pulmón. Consenso nacional de la Sociedad Española de Radiología Médica y la Sociedad Española de Oncología Médica.
Radiologia
; 57(1): 66-78, 2015.
Artigo
Espanhol
| MEDLINE | ID: mdl-25530188
9.
The EPICAL trial, a phase Ib study combining first line afatinib with anti-EGF vaccination in EGFR-mutant metastatic NSCLC.
Lung Cancer
; 164: 8-13, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34971901
10.
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation.
Eur Respir J
; 37(3): 624-31, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-20595147
11.
Successful Oral Desensitization in a Patient With Hypersensitivity Reaction to Crizotinib.
J Investig Allergol Clin Immunol
; 25(4): 307-8, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26310051
12.
Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group.
Lung Cancer
; 147: 83-90, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32682189
13.
SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018).
Clin Transl Oncol
; 21(1): 3-17, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30446985
14.
Immune checkpoint inhibitors in non-small cell lung cancer (NSCLC): Approaches on special subgroups and unresolved burning questions.
Cancer Treat Rev
; 64: 21-29, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-29454155
15.
Immunotherapy for oncogenic-driven advanced non-small cell lung cancers: Is the time ripe for a change?
Cancer Treat Rev
; 71: 47-58, 2018 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-30359792
16.
Ocular surface adverse events of systemic epidermal growth factor receptor inhibitors (EGFRi): A prospective trial.
J Fr Ophtalmol
; 41(10): 955-962, 2018 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-30473235
17.
miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers.
Clin Transl Oncol
; 18(2): 153-9, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26199015
18.
Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategies.
Cancer Treat Rev
; 41(1): 27-34, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25467107
19.
Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology.
Clin Transl Oncol
; 17(1): 11-23, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25373531
20.
Integrating concurrent navelbine and cisplatin to hyperfractionated radiotherapy in locally advanced non-small cell lung cancer patients treated with induction and consolidation chemotherapy: feasibility and activity results.
Lung Cancer
; 45(1): 67-75, 2004 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-15196736